← All trials
NCT02369978
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2015
- Primary completion
- Feb 1, 2017
- Completion date
- Feb 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 500
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Universidad Autónoma de BucaramangaLead sponsor
- Universidad Autónoma de BucaramangaCollaborator
- Universidad Autónoma de BucaramangaOverall official - principal investigator
- Universidad Autónoma de BucaramangaReponsible party - principal investigator
- Fundación Cardioinfantil Instituto de CardiologíaCollaborator
- Instituto Nacional de Salud (Colombia)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.